| Christopher Scott Plummer, | |
|
1795 Whiskey Rd, Aiken, SC 29803-7337 | |
| (803) 642-5371 | |
| Not Available |
| Full Name | Christopher Scott Plummer |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1795 Whiskey Rd, Aiken, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922761014 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 43206 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Scott Plummer, 126 Inwood Dr, Aiken, SC 29803-5614 Ph: (803) 640-4177 | Christopher Scott Plummer, 1795 Whiskey Rd, Aiken, SC 29803-7337 Ph: (803) 642-5371 |
News Archive
Sanofi-aventis announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana (cabazitaxel) Injection, was published in the October 2, 2010 print edition of The Lancet in an article titled "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, has been awarded a $750,000 grant to further her research into a possible treatment for Alzheimer's disease. The grant is from the Edward N. And Della L. Thome Memorial Foundation, and was one of only eight Awards in Alzheimer's Disease Drug Discovery Research to be given in the U.S. in 2010.
A new individualized systems medicine strategy, developed at the Institute for Molecular Medicine Finland FIMM and the Helsinki University Central Hospital, enables a selection of potentially effective cancer therapies for individual patients. The promising results achieved by applying this strategy to chemoresistant adult acute myeloid leukemia patients have been recently published in the Cancer Discovery journal.
In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.
› Verified 3 days ago
Alex Beams, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 190 Crepe Myrtle Dr, Aiken, SC 29803 Phone: 803-648-7800 Fax: 803-648-7277 | |
Karen Newsom, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3581 Richland Ave W, Aiken, SC 29801 Phone: 803-648-6464 | |
Veronica L Macmillan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2191 Whiskey Rd, Aiken, SC 29803 Phone: 803-648-8155 | |
Alan Martin Kaufman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1795 Whiskey Rd, Aiken, SC 29803 Phone: 803-642-5371 Fax: 803-642-5417 | |
Benjamin Palmer Kirby, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1795 Whiskey Rd, Aiken, SC 29803 Phone: 803-642-5371 | |
Dr. Ryan P Watts, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Richland Ave W, Aiken, SC 29801 Phone: 513-238-2467 | |
Mrs. Carol Ann H Voigt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Eastgate Dr, Aiken, SC 29803 Phone: 803-643-7976 |